Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $9.8500 (9.44%) ($8.7900 - $9.9200) on Mon. May. 4, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.31% (three month average) | RSI | 72 | Latest Price | $9.8500(9.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.3% a day on average for past five trading days. | Weekly Trend | AUTL advances 4.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(22%) IBB(21%) ARKG(20%) SKYY(19%) XLK(18%) | Factors Impacting AUTL price | AUTL will decline at least -3.655% in a week (0% probabilities). VIXM(-14%) VXX(-10%) TBT(-7%) UNG(-4%) SHY(-1%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.655% (StdDev 7.31%) | Hourly BBV | 0 () | Intraday Trend | 9.7% | | | |
|
5 Day Moving Average | $9.66(1.97%) | 10 Day Moving Average | $9.78(0.72%) | 20 Day Moving Average | $8.92(10.43%) | To recent high | -11.9% | To recent low | 92.8% | Market Cap | $515m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |